Impact of Planter Flexors Spasticity on Postrual Stabilty and Functional Outcome in Pateints With Stroke
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Low spasticity group, High spasticity group.
- Who it may be relevant to
- Registry conditions: Stroke. Basic parameters: 45 years — 60 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
this study will be conducted to investigate the effect of planter flexors spasticity on postural stability, risk of falling and function outcomes in patients with stroke
Detailed description
Lower limb spasticity is a common following a cerebrovascular attack (CVA) or stroke, which can affect the balance and gait of patients. This then not only affects independence, and quality of life but increases the risk for other concerns, such as falling and an increased sedentariness, which could further affect health outcomes.The spasticity of the planter flexors disturbs walking, can impede toe clearance during the swing phase of gait causing the patient to fall as a result their toe 'catching' on the ground .In stroke patients characteristically the extensors of the leg are spastic and the flexors are weak . All these changes lead to gait disturbance as well as impaired functional mobility of patients.Studies have shown that patients with stroke have a higher risk of developing the fear of falling, which may be related to an increased risk of falling after stroke .The incidence of fear of falling after stroke has been reported to be approximately 32 to 66 percent. Fear of falling is associated with adverse consequences such as limited activity, increased incidence of falls, decreased quality of life, and increased hospitalization and case fatality rates
Interventions
- Other Low spasticity group
low sapsticity (grade 1-2) unilateral ischemic stroke will be participate in this group - Other High spasticity group
high sapsticity (grade 3-4) unilateral ischemic stroke will be participate in this group
Primary outcome measures
- spasticity [Time frame: up to thirty minutes]
- muscle spasticity [Time frame: up to thirty minutes]
- postural stability [Time frame: up to thirty minutes]
- risk of falling index [Time frame: up to thirty minutes]
- risk of falling [Time frame: up to thirty minutes]
- functional mobility [Time frame: up to thirty minutes]
Eligibility criteria
Inclusion criteria
- Sixty eight first-ever unilateral ischemic stroke patients as diagnosed by CT ''computed topography'' or MRI ''magnetic resonance imaging.
- Patients will be both sexes.
- Their age ranges from 45 to 60 years
- The patients will be divided into 2 groups based on their level of ankle plantar flexor spasticity according to the Modified Ashworth Scale (MAS):
- Low spasticity (grade 1 and 1+).
- High spasticity (grade 2 and 3).
- Duration of illness will be over 6 months post-stroke.
- Body mass index of patients will be ≤ 30 kg / m2
- Patients can stand independently.
- Normal cognitive abilities according to MOKA scale will be ≥ 24
Exclusion criteria
- Bilateral hemiplegia.
- Patients having any other neurological disorders affecting their lower limb extremity as MS, Parkinson disease, peripheral neuropathy.
- Patients with visual auditory impairment affecting their ability to complete task. 4.Patients with previous fracture of the lower limbs or any other musculoskeletal disorders such as severe arthritis, fixed ankle contracture, ankle surgery, leg length discrepancy or being treated with botulinum toxin injections within the past 3 months of study participation.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07174037 · P.T.REC/012/005968